Back to search
Critical Limb Ischemia Due to Buerger's Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Critical Limb Ischemia Due to Buerger's Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Critical Limb Ischemia Due to Buerger's Disease trials you may qualify forA prospective, open label, controlled, randomized, double arm, multi-center study to assess the efficacy and safety of CLBS12 in patients with critical limb isc…
This study is being conducted as an extension of the phase II clinical trial SRPL/CLI/10-11/001 (NCT01484574). The CDSCO has recommended flexibility for continu…
This is an open label, non-randomized, dose ranging study to evaluate the safety and efficacy of different doses of Stempeucel in critical limb ischemia patient…